Labs & Biomarkers
How to interpret ApoB, HOMA-IR, hs-CRP, ferritin, and other markers that reveal risk decades before diagnosis.
Overview
What this system actually governs
Bloodwork is the cheapest window into physiology most people will ever have, and it is routinely under-read. The core problem is the reference range: it describes the middle 95% of the people who happened to get tested at that laboratory, not the range associated with the lowest risk. A result can be inside the range and still describe a decade-long trajectory toward metabolic disease. Reading labs well means separating three questions — is this value optimal rather than merely normal, is it moving, and does it agree with the other markers measuring the same system?
The markers that carry the most information
For cardiovascular risk, ApoB or non-HDL cholesterol carries more information than LDL-C alone because it counts atherogenic particles rather than the cholesterol inside them; Lp(a) is largely genetic and worth measuring once. For metabolic health, fasting insulin, HOMA-IR, triglyceride-to-HDL ratio, and HbA1c together detect insulin resistance years before fasting glucose moves. For inflammation, hs-CRP with ferritin and white-cell differential distinguishes chronic low-grade inflammation from acute response. For nutrient status, ferritin with transferrin saturation, vitamin D, B12 with methylmalonic acid, and RBC magnesium each avoid the blind spots of the single-marker version.
Where the frontier work is
Active research clusters around ApoB as the preferred lipid target, Lp(a)-lowering therapies in trials, continuous glucose monitoring in non-diabetics and what the variability actually predicts, epigenetic and proteomic aging clocks and their still-unproven clinical utility, GlycA and other composite inflammation markers, and the growing use of intra-individual trend data rather than single population-referenced snapshots.
How to read this hub
Tier 1 entries explain what each marker measures, what an optimal range looks like, and which combinations matter. Tier 2 entries go into assay limitations, biological variability, pre-analytical error, when a marker is a cause versus a bystander, and how to build a repeatable personal panel without over-testing.
Foundational — Tier 1 primers
0 articlesPrimers for this hub are being prepared.
Deeper — Tier 2 investigations
5 articlesHeart Rate Variability: Reading the Autonomic Signal
HRV is the most useful daily biomarker most people own and the easiest one to misread. The trend is the signal; the single morning number is mostly noise.
The Omega-3 Index: A Biomarker Worth Measuring
Fish oil intake tells you almost nothing. Red blood cell membrane composition tells you where you actually stand — and it is one of the strongest mortality predictors in the lipid space.
Rethinking Blood Pressure: Beyond the Single Number
A cuff reading is a snapshot of a dynamic system. The pattern across time, and the pressure inside the artery wall, carry more information than any single value.
Statins and Cholesterol: Context, Evidence, and an Informed-Decision Framework
A risk-aware, evidence-led guide to statin therapy that puts absolute benefit, metabolic context, and patient choice ahead of simplistic narratives.
ApoB, Not LDL: Rewriting the Cardiovascular Risk Model
Why particle count outperforms cholesterol concentration for predicting atherosclerosis — and how to read your own results.
Frequently asked questions
- If my results are "normal," is there anything left to look at?
- Often yes. Reference ranges are statistical descriptions of a tested population, not risk thresholds. Fasting insulin, triglyceride-to-HDL ratio, and ApoB frequently sit inside the range while already indicating a worsening trajectory.
- Which single test gives the most information about metabolic health?
- Fasting insulin, ideally alongside glucose so HOMA-IR can be calculated. It usually shifts years before HbA1c or fasting glucose leave the normal range.
- How often should labs be repeated?
- For most stable adults, once a year, or eight to twelve weeks after a deliberate change in diet, training, or medication — long enough for the marker to respond and short enough to attribute the change.
Related hubs
Browse the complete archive →Glucose variability, insulin sensitivity, and substrate flexibility.
Cellular energy production and the mechanisms of senescence.
Cytokine signaling and chronic low-grade systemic stress.
Hypertrophy, sarcopenia prevention, and structural health.